Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Rifaximin Therapy on Intestinal Byproducts in Chronic Kidney Disease

NCT02342639 is registered in ClinicalTrials.gov with Jason Stubbs, MD as lead sponsor.

NCT NCT02342639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Rifaximin Therapy on Intestinal Byproducts in Chronic Kidney Disease
Lead sponsor
Jason Stubbs, MD
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2015
Completion date
March 1, 2019
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease